Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Diabetes and Endocrinology

Diabetes and Endocrinology current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email to subscribe.

May 2024

Adequacy of thyroid hormone replacement for people with hypothyroidism in real-world settings 10.1111/cen.14998

Atypical diabetes: what have we learned and what does the future hold? 10.2337/dci23-0038

Beyond the bias! Sex distribution in paediatric growth hormone deficiency reexamined 10.1111/cen.15047  

Clinical and immunological characteristics of children diagnosed with—type 1 diabetes during the COVID-19 pandemic 10.1111/dme.15250

Diabetic complications and risk of depression and anxiety among adults with type 2 diabetes 10.1111/dme.15272  

Emotional distress predicts reduced type 2 diabetes treatment adherence in the glycemia reduction approaches in diabetes 10.2337/dc23-1401

Evaluation of quality of life in children with precocious puberty 10.1111/cen.15033  

The Fusion Clinic: integrating the care of people with severe mental illness and diabetes 10.1111/dme.15255  

Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service 10.1111/cen.15038  

Identifying preferred features of weight loss programs for adults with or at risk of type 2 diabetes: a discrete choice experiment with 3,960 adults in the UK 10.2337/dc23-2019

The impact of stigma on the management of type 1 diabetes: a systematic review 10.1111/dme.15299  

Initial surgical management of sporadic medullary thyroid cancer 10.1111/cen.15041  

Optimising glycaemic control in people with type 1 diabetes (new SIGN guideline 170)

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19 10.1111/cen.15012  

Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use 10.2337/dci23-0040

Roles and competencies of the clinical psychologist in adult diabetes care—a consensus report 10.1111/dme.15312  

Socioeconomic deprivation and the risk of sight-threatening diabetic retinopathy (STDR): a population-based cohort study in the UK 10.2337/dc23-1626

Steroidogenic acute regulatory protein (STAR) deficiency: our experience and systematic review for phenotype–genotype correlation 10.1111/cen.15032  

Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer 10.1111/cen.15027


Clinical Endocrinology (Apr-May); Diabetes Care (Apr); Diabetic Medicine (Apr-May); SIGN website (Mar)

March 2024

Application of CRISPR-Cas9 technology in diabetes research 10.1111/dme.15240  

Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes 10.1111/dme.15280  

Effects of different insulin sensitisers in the management of polycystic ovary syndrome 10.1111/cen.14983

Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England 10.1111/dme.15232  

Gestational diabetes: One size does not fit all—an observational study of maternal and neonatal outcomes by maternal glucose profile 10.1111/dme.15205  

Hospital admissions among people with diabetes 10.1111/dme.15236  

Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma 10.1111/cen.15001

Inequalities in the management of diabetic kidney disease in UK primary care 10.1111/dme.15153  

Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study 10.1111/dme.15249  

Lymph node imaging for thyroid cancer 10.1111/cen.14993  

Managing adults with hypoglycemia 10.1016/j.annemergmed.2023.07.019

New advances in type 1 diabetes 10.1136/bmj-2023-075681

Men, testosterone and COVID-19 10.1111/cen.14952  

Outcomes measured in studies assessing health systems interventions for type 1 diabetes management 10.1111/dme.15223  

The psychosocial burdens of living with diabetes 10.1111/dme.15219

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary adenomas in adults 10.1002/14651858.CD013561.pub2

Systematic review of guidelines on neonatal hypoglycemia 10.1111/cen.14995

Telemedicine in the treatment of gestational diabetes 10.1111/dme.15201  

A UK national survey of enteral feed use in people with diabetes 2022 10.1111/dme.15216  

The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency 10.1111/cen.14999


Annals of Emergency Medicine (Dec); BMJ (26th Jan); Clinical Endocrinology (Jan-Mar); Cochrane Library (Jan-Feb); Diabetic Medicine (Jan-Mar)

January 2024

Associations between maternal gestational diabetes metformin or insulin treatment and offspring growth trajectories from birth to 60 months of age: Findings from the Born in Bradford (BiB) study DOI: 10.1111/dme.15204

Biological variation in thyroid function tests in older adults and clinical implications DOI: 10.1111/cen.14973

Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism DOI: 10.1111/cen.14945

The dangerous trend of levothyroxine medicalization DOI: 10.1016/j.tem.2023.08.017

Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England DOI: 10.1111/dme.15209

Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease DOI: 10.1038/s41467-023-42284-5

The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment DOI: 10.1111/dme.15230

The journey towards implementation of the NHS Diabetes Prevention Programme: A personal perspective DOI: 10.1111/dme.15191

Macronutrient intake in children and adolescents with type 1 diabetes and its association with glycemic outcomes DOI: 10.1155/2023/7102890

Pregnancy, delivery and neonatal outcomes among women with hypoparathyroidism—A population-based study DOI: 10.1111/cen.14969

Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set DOI: 10.1111/cen.14964

Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta-analysis DOI: 10.1111/dme.15173

Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency DOI: 10.1111/cen.14975

Road map for personalized exercise medicine in T2DM DOI: 10.1016/j.tem.2023.08.013

Trends in incidence of ischaemic stroke in people with and without diabetes in Ireland 2005–2015 DOI: 10.1111/dme.15127

Type 1 diabetes in the pancreas: A histological perspective DOI: 10.1111/dme.15228

Wearable digital health technologies in medicine: digital technology for diabetes (review) DOI: 10.1056/NEJMra2215899

What can functional brain imaging teach us about remission of type 2 diabetes? DOI: 10.1111/dme.15235

Sources used: Clinical Endocrinology (Nov, Dec); Diabetic Medicine (Nov, Dec); Nature Communications (Oct); NEJM (30th Nov); Pediatric Diabetes (Nov); Trends in Endocrinology and Metabolism (Dec)